• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Kronos downgraded by TD Cowen

    11/14/24 7:42:59 AM ET
    $KRON
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $KRON alert in real time by email
    TD Cowen downgraded Kronos from Buy to Hold
    Get the next $KRON alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $KRON

    DatePrice TargetRatingAnalyst
    11/14/2024$6.00 → $1.00Overweight → Neutral
    Piper Sandler
    11/14/2024Buy → Hold
    TD Cowen
    9/14/2022$12.00Buy
    Berenberg
    2/28/2022$50.00 → $30.00Overweight
    Piper Sandler
    11/10/2021$35.00 → $36.00Buy
    HC Wainwright & Co.
    10/20/2021Outperform
    Cowen
    6/24/2021$35.00Buy
    HC Wainwright & Co.
    More analyst ratings

    $KRON
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Bischofberger Norbert W

      4 - Kronos Bio, Inc. (0001741830) (Issuer)

      6/20/25 4:15:37 PM ET
      $KRON
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by Director Belldegrun Arie

      4 - Kronos Bio, Inc. (0001741830) (Issuer)

      6/20/25 4:15:41 PM ET
      $KRON
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Director Ridloff Elena closing all direct ownership in the company (SEC Form 4)

      4 - Kronos Bio, Inc. (0001741830) (Issuer)

      6/20/25 4:15:35 PM ET
      $KRON
      Biotechnology: Pharmaceutical Preparations
      Health Care